VERTANICAL GmbH
- Biotech or pharma, therapeutic R&D
First-in-class, non-addictive, breakthrough cannabinoid-based drug for the treatment of chronic pain with Phase 3 data demonstrating highly efficacious pain reduction and a strong safety profile
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}